Testing a bacteria cream for eczema (TIME-2)
Treatments studied
Part of Genetic & congenital, Immune system & allergy, Skin clinical trials.
This study tests whether a cream made from a friendly skin bacteria (Staphylococcus hominis) can help treat eczema. Eligible participants will apply the cream to eczema patches on their arms, legs, or trunk for several weeks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 6 years old.
- You need to have eczema patches on your arms, legs, or torso (not on your face, neck, hands, or feet) that add up to about the size of a credit card or larger.
- Your eczema should cover at least 3% of your body.
- You cannot be pregnant, nursing, or planning to become pregnant during the study.
- You cannot have used certain strong eczema treatments (like Dupixent) in the past 4 months or other prescription creams in the past week.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new injectable medicine called FB825 for people with moderate to severe eczema that hasn't improved enough with standard creams. The study aims to see if FB825 can reduce itching and skin symptoms safely.
This study tests whether cleaning the skin to remove a common bacteria (Staph aureus) can help reduce eczema symptoms. It may offer a new way to manage eczema without relying only on creams or injections.
This study tests a new ointment containing probiotics (good bacteria) to see if it helps with eczema in children. It is a cream that is applied to the skin, and the goal is to see if it reduces the itching and redness.
This trial tests a new dermocosmetic cream for children with eczema. It looks at how well the cream works and how gentle it is on the skin, after the child uses a prescribed steroid cream to calm a flare-up.
This trial tests whether a cosmetic cream can reduce eczema flare-ups and is comfortable/safe to use on very dry, irritated, eczema-prone skin. It’s mainly for children who have had recent flare-ups and moderate eczema severity.
This study tests an investigational cream for moderate to severe eczema. It helps see if the cream reduces symptoms like itching and skin inflammation.
Hear when a new Atopic Dermatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.